Panacea Innovation Ltd - Jan 30, 2025 SCHEDULE 13G Report for Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share (ATRA)

Filing Manager
Panacea Innovation Ltd
Reporting Manager
Panacea Venture Healthcare Fund II, L.P.
Security
Atara Biotherapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
ATRA
Shares outstanding
5.79M shares
Disclosed Ownership
550K shares
Ownership
9.5%
Form type
SCHEDULE 13G
Date filed
2/6/2025, 06:34 PM
Date of event
Jan 30, 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Panacea Venture Healthcare Fund II, L.P. 9.5% 550K 0 550K By: Panacea Venture Healthcare Fund II GP Company, Ltd., its general partner, By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Venture Healthcare Fund II GP Company, Ltd. 9.5% 550K 0 550K By: Panacea Innovation Limited, its sole owner, /s/ James Huang James Huang, Founding Managing Partner
Panacea Innovation Limited 9.5% 550K 0 550K /s/ James Huang James Huang, Founding Managing Partner
James Huang 9.5% 550K 0 550K /s/ James Huang James Huang